Pharmaceutical Preparations · DE · CIK 1774857
Develops novel small-molecule therapeutics targeting bitter taste receptors for metabolic diseases like hyperphagia
Comparable business profile · signals at a glance
In the 90 days to Dec 11, 2025: 2 insiders bought $145K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 11, 2025 | Lee Tien-LiChief Executive Officer | Buy | 7,000 | $14.49 | $101K |
| Dec 11, 2025 | Sun NelsonChief Financial Officer | Buy | 3,000 | $14.40 | $43K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.